Viking Therapeutics initiates Phase 2 VENTURE-oral dosing trial of VK2735
Viking Therapeutics (VKTX) announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company’s dual ...
Inquirer on MSN3mon
Ampalaya now a real bitter pill to treat diabetes
Ampalaya (Momordica charantia) is rich in bioactive compounds, including polypeptide-p ... “Our studies have shown that the ...
Stockhouse15d
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
today announced the initiation of a Phase 2 clinical trial of the oral tablet formulation of VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent ...